4.7 Article

Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy

Journal

NANOPHOTONICS
Volume 11, Issue 22, Pages 5101-5111

Publisher

WALTER DE GRUYTER GMBH
DOI: 10.1515/nanoph-2022-0289

Keywords

immunotherapy; metabolism; natural killer cells; selenium nanoparticles; selenoprotein

Funding

  1. Natural Science Foundation of China [21877049]
  2. Science and Technology Program of Guangzhou [202102010012]
  3. Guangzhou Basic and Applied Basic Research Foundation [202201010339]
  4. Fundamental Research Funds for the Central Universities [21621053]

Ask authors/readers for more resources

This study demonstrates that selenium nanoparticles combined with metformin can enhance the immunotherapeutic effects of NK cells against osteosarcoma cancer. The nanoparticles are metabolized into selenoproteins, which regulate the redox balance in the tumor microenvironment and reinforce the anticancer effect of NK cells.
NK cells-based cancer therapy combined with chemotherapeutic drugs for the treatment of tumors can enhance the immunosensitivity of NK cells, increase the expression of NK cell receptors, and eventually boost the killing effect of NK cells on cancer cells. Selenium (Se) with different chemical structures can be metabolized into selenoproteins to regulate tumor and immune cells' fate and functions. Herein, we found that, functionalized Se nanoparticles (SeNPs) combining with metformin (met) could amply the immunotherapeutic effects of NK92 cells against osteosarcoma cancer. The results revealed that TW80-SeNPs combined with met had the optimum performance on NK92 cells for HepG2 cells, owing to the increased ROS in HepG2 cells and the augmented expression of cell surface receptor proteins ULBP-3/4, PD-L1, MICA, and NK92 cell surface receptor proteins PD-1 and FasL. Additionally, TW80-SeNPs were gradually metabolized into selenoproteins (Gpx4 and TR1) into human osteosarcoma MG63 cells to reinforce the anticancer effect of NK92 cells by regulating the redox balance in the tumor microenvironment. This study provides a therapeutic approach in treating cancer itself or diabetes coupled with cancer. Moreover, it provides a multidrug strategy to improve immune cell function in practical applications, especially for synergistic immunotherapy of osteosarcoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available